Jeffrey W. Sherman, Director at Larimar Therapeutics, Inc. (LRMR), bought 5,000 shares at $5.00 ($25K) on 2026-02-27, disclosed to the SEC on 2026-03-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| HZNP | SELL | 2023-01-12 | $1.5M | — | Filing → |
| HZNP | SELL | 2023-01-06 | $1.2M | — | Filing → |
| HZNP | SELL | 2022-12-13 | $6.3M | — | Filing → |